Pramila Rijal

Career Development Fellow @UniofOxford @CAMS_COI_Ox @MRC_TIDU @MRC_WIMM
RT≠Endorsement

[Pramila Rijal @prarija]

Here's a graphical abstract for a quick overview

[Pramila Rijal @prarija]

🚀 Exciting news! Our findings on influenza neuraminidase protein engineering are now available as a preprint on bioRxiv! https://t.co/xzIGD6TQA0… #Influenza #neuraminidase

[bioRxiv Immunology @biorxiv_immuno]

Loop Grafting Improves Neuraminidase Protein Vaccine Production https://t.co/fFJaVEEwB8 #biorxiv_immuno

[Pramila Rijal @prarija]

Acknowledgement to the key project funder CAMS Innovation Fund for Medical Science (CIFMS), and @CAMS_COI_Ox @MRC_TIDU @RDMOxford @MRC_WIMM

[Pramila Rijal @prarija]

Thanks to all co-authors for their contributions! 🙏 #Collaboration #ScienceCommunity ..and thanks for reading!

[Eve Richardson @EveRichardson20]

BCR repertoire sequencing in 40 Ad26.ZEBOV/MVA-BN-Filo vaccinees in work with @OxVaccineGroup:

[CAMS Oxford Institute @CAMS_COI_Ox]

Another day, another chance to #WorkAtCOI...Join @prarija to work as a post-doctoral #ResearchAssistant @MRC_WIMM & @CAMS_COI_Ox. You will be looking at using #Influenza neuraminidase as a target for #VaccineDevelopment and novel drug discovery. Apply here:https://t.co/CHamBJFOHM

[Pramila Rijal @prarija]

#jobadvert seeking motivated postdoctoral researcher to work on exciting projects on novel #drug_discovery and #vaccine_development targeting #Influenza #neuraminidase. Application closes 3May Please share @CAMS_COI_Ox @MRC_WIMM @MRC_TIDU @UniofOxford https://t.co/KT3YbJgwrv

[Pramila Rijal @prarija]

We are seeking a motivated postdoctoral researcher to work on an exciting project focused on novel #drug_discovery and #vaccine_development targeting #Influenza #neuraminidase. Application closes on 3 May 2024. Please share #jobadvert
https://t.co/KT3YbJgwrv

[Pramila Rijal @prarija]

@CAMS_COI_Ox @TaoDong14 @NDMOxford @MRC_WIMM @MRC_HIU @UnivOxford Congratulations @TaoDong14 🎊

[CAMS Oxford Institute @CAMS_COI_Ox]

A new #ReviewArticle by @prarija has been published in @elsbiomedchem Current Opinion in Virology, looking at the use of broadly protective #MonoclonalAntibodies to treat #Ebola virus disease. Read the full article here: https://t.co/Fruys7xFka
#AcademicTwitter #CurrentOpinion

[Pramila Rijal @prarija]

@giiseleveiga @Virusnerdette @McLellan_Lab @ScienceMagazine @IlyaFinkelstein We started using 5 ml Histrap columns (Thermo Fischer) for 50 - 200 ml protein supernatant and that helped. Previously we were using 1 ml columns.

[Pramila Rijal @prarija]

@AE_Preston @Drakesmith_Lab Congratulations :)

[Prof. Devi Sridhar @devisridhar]

Early Sat talking about this Guardian piece on Sky- H5N1 is a known disease. Risk to public is low now but should be high priority for govts. Surveillance, testing, antivirals & vaccines (1/3). https://t.co/WWpzjNauZC

[Pramila Rijal @prarija]

https://t.co/Y6FnujV5Ub

[Jurre Y Siegers, PhD @jurreysi]

@thijskuiken There seems to be a translation error from Khmer to English. The report below (in khmer) states there are 12 contacts to the index case and 4 amongst those 12 report flu like symptoms. https://t.co/N1ItxLhaUK

[Pramila Rijal @prarija]

No human-to-human transmissions have been established yet but the rise in numbers of human H5N1 infections is worrying!

[Jeremy Farrar @JeremyFarrar]

After death of girl yesterday, 12 more detected with H5N1 bird flu in Cambodia - Khmer Times https://t.co/ejHHKIWnmD